Search Our Site

Solutions for Carriers, Workers' Comp, TPAs, MGUs, Health Plans, Reinsurers, and Taft-Hartley Health Plans
PredictDx

Annual costs and standard treatments for catastrophic diagnoses are now at your fingertips

PredictRx

Approved indications, off-label usage, reasonable costs and Medicare reimbursement for pharmaceuticals

implantDx

Regional prices paid by providers for 175,000+ implants are now at your fingertips

55%

reduction in claims cost

stat_icon

72%

increase in quality assurance

stat_icon

85%

saved on average

stat_icon

For Every Service We Perform, Your Success is Our Priority

As a physician-led organization, Advanced Medical Strategies brings forth some of the most innovative & proactive solutions in the Health Care and Workers' Compensation Payor industry today. In addition to saving our clients time and money, we provide peace of mind when dealing with all complicated pieces that can happen when reimbursing claims.

What We Achieve

♦ A clinical and financial view of claims to produce the best possible outcome

♦ Claims savings via fair and defensible claim reviews

♦ Peace of mind with unbiased clinical reviews in complex cases

♦ Simplification of complex cases through complimentary screening process

♦ Maintaining collaborative relationships by recognizing payor politics

  • As rising drug costs have become a topic of intense debate, a new review finds a significant increase for some cancer drugs. The cost of certain oral medications for cancer treatment have increased multiple-fold since 2000, according to a study published today in the Journal of the American Medical Association. The average cost for certain... Read More »
  • Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial Background Dupilumab, a fully human anti-interleukin-4 receptor α monoclonal antibody, inhibits interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated inflammation. Adults with uncontrolled persistent asthma... Read More »

OUR PROVEN TRACK RECORD SPEAKS FOR ITSELF

10+M

dollars Saved

We have saved tens of millions of dollars for our clients and subscribers

100%

Subscribers Retained

We have retained 100% of our subscribers

700+

Sub Specialty Physicians

700+ specialty physicians in our peer review panel

100's

Weekly Hours Saved

We have saved our clients and subscribers 100's of weekly hours in research, analysis, and underwriting